Oxford's statement: Two full doses of the Covishield vaccine are very effective; The outcome of the first one and a half dose was questioned

 Welcome to mbctalk,

                   Two full doses of the Corona vaccine (Covishield) from Oxford University and AstraZeneca are responding well. Oxford University gave this information on Thursday night. The university said in a statement: "Earlier we did a trial by giving one full and one-half dose. I.e., the candidate was given one and a half doses. Now full doses were given. The results were very good.

About a month ago, AstraZeneca and Oxford admitted to a manufacturing error in the vaccine. The results of the third phase of the vaccine trial were then announced, with different results.

TWO FULL DOSES ARE MUST

Oxford gave new information about its vaccine in a statement released on Thursday. That said, we gave our candidate two full doses of the vaccine during the trial. The results were good. Earlier we gave one full and one-half dose, compared to which two full doses proved to be very effective.

The company's latest statement comes at a time when it has admitted to a different outcome in recent days. Experts then also questioned its data analysis. In a new statement, Oxford acknowledged that more work was needed to confirm the outcome of the vaccine.

REVEALED THREE-PHASE INFORMATION

Oxford announced the results of Phase 1 to Phase 3 trials for the second time in a month. This, however, does not refer to the one-and-a-half doses previously given. The university says trials to give one and a half doses were not pre-determined. Now Oxford's focus is on giving two full doses for its vaccine. He says experimenting with one and a half and two doses was part of his strategy, for which questions have already been raised, as it is natural for differences in doses to result in differences.

Oxford said the results from booster doses showed that antibodies were formed faster than single doses. Standard doses must be used.